Neuroprofiler Investor Profiler neuroprofiler.com

Neuroprofiler Investor Profiler

Based on the latest advances of Behavioral Finance, Neuroprofiler is a MiFIDII-compliant customer Risk Profiler for Financial Advisors

history traffic contact

OVERVIEW

This website neuroprofiler.com currently has an average traffic classification of zero (the smaller the superior). We have probed zero pages inside the domain neuroprofiler.com and found three websites linking to neuroprofiler.com. There are one contacts and directions for neuroprofiler.com to help you communicate with them. This website neuroprofiler.com has been on the internet for nine hundred and twenty-four weeks, seventeen days, six minutes, and fifteen seconds.

Links to this site

Contacts

Locations

Online Since

Jul 2007

NEUROPROFILER.COM RANKINGS

This website neuroprofiler.com has seen fluctuating quantities of traffic within the past the year.

Date Range

1 week

1 month

3 months

This Year

Last Year

All time

Traffic ranking (by month) for neuroprofiler.com

Date Range

All time

This Year

Last Year

Traffic ranking by day of the week for neuroprofiler.com

Date Range

All time

This Year

Last Year

Last Month

NEUROPROFILER.COM HISTORY

This website neuroprofiler.com was started on on July 20, 2007. This site was updated on July 15, 2013. This site will expire on the date of July 20, 2014. It is now nine hundred and twenty-four weeks, seventeen days, six minutes, and fifteen seconds old.

REGISTERED

July

2007

UPDATED

July

2013

EXPIRED

July

2014

MATURITY

YEARS

MONTHS

DAYS

LINKS TO WEB PAGE

WHAT DOES NEUROPROFILER.COM LOOK LIKE?

CONTACTS

HOSTGATOR

ADAM FARRAR

5005 MITCHELLDALE SUITE #100

HOUSTON, TX, 77092

1.7135745287

DOMAINS@HOSTGATOR.COM

NEUROPROFILER.COM HOST

I observed that a single root page on neuroprofiler.com took one hundred and eighty-eight milliseconds to download. We discovered a SSL certificate, so therefore our web crawlers consider neuroprofiler.com secure.

Load time

0.188 seconds

SSL

SECURE

Internet Address

104.198.14.52

NAME SERVERS

ns595.hostgator.com

ns596.hostgator.com

WEBSITE IMAGE

SERVER OPERATING SYSTEM AND ENCODING

I diagnosed that this website is using the Netlify os.

PAGE TITLE

Neuroprofiler Investor Profiler

DESCRIPTION

Based on the latest advances of Behavioral Finance, Neuroprofiler is a MiFIDII-compliant customer Risk Profiler for Financial Advisors

CONTENT

This website neuroprofiler.com states the following, "Based on the latest advances of Behavioral Finance, Neuroprofiler is a MiFIDII-compliant customer Risk Profiler for Financial Advisors." Our analyzers viewed that the webpage also stated " How is client suitability assessed today? Of clients profiling tools are based on scientific research." The Website also said " Of clients profiling tools are compliant. Of clients want more digitalization and customisation. Neuroprofiler covers the whole client appropriateness and suitability process as required by MiFIDII. 50 are not compliant with local regulation FCA 2011."

VIEW SUBSEQUENT DOMAINS

NeuroProgramador

Herramientas y Soluciones a problemas de pensamiento, dialogo interno y de salud emocional. Sábado, 18 de junio de 2011. Que el paciente aprenda nuevas técnica.

NeuroProgramador Herramientas Intelectuales para Ser y Pensar Diferente.

Herramientas Intelectuales para Ser y Pensar Diferente. Mi odómetro llegó a los 90 .

NeuroProject

Ломоносова на базе НИИ ядерной физики МГУ. Занятия будут проходить два раза в неделю в вечернее время. Дата начала занятий - 27 февраля 2018 г. Если Вы хотите всегда б.

Istituto Superiore di Sanità Benvenuti

Seguendo questo link salti il contenuto della pagina e vai direttamente alla Mappa del sito a fondo pagina. Cancro del colon, nasce la prima rete tra i Paesi del Mediterraneo per contrastarlo. ISS, 15 settembre 2017.

Phenotypic Screening with MEA Neurochip Technology - NeuroProof

NeuroProof is a CRO delivering services with its unique functional in vitro screening technology, which delivers high content phenotypic endpoints for customers in pre-clinical drug development with the goal to accelerate CNS drug development projects cost effectively. Functional Abeta42 rescue assay for novel Alzheimer drugs. Functional MPP Prevention assays for novel Parkinson drugs.